← Back to Dashboard
Litigation Stage Tracker
Early / MonitoringEmerging
Formation
Active Litigation
Maturation
<45
45–55
55–70
70+
IVC Filter
ClosedFLATMDL 2641Device
3,800+
Total Cases
Causation
Retrievable IVC filters were designed for temporary blood clot prevention but frequently could not be safely removed. Device failures include filter fracture (strut breakage), migration from the vena cava to the heart or lungs, tilting causing vena cava perforation, and thrombotic occlusion. The FDA issued a 2010 safety communication recommending retrieval within 29-54 days, but retrieval rates remained below 30%. Bard internal documents showed fracture rates up to 25% for certain models.
Defendants
| Entity | Role | Note |
|---|---|---|
| C.R. Bard / BD | Manufacturer | Recovery and G2 series IVC filters — primary defendant |
| Becton Dickinson (BD) | Parent Company | Acquired Bard in 2017 — assumed IVC filter liabilities |
| Cook Medical | Manufacturer | Celect and Gunther Tulip IVC filters — co-defendant |
| Boston Scientific | Manufacturer | Greenfield IVC filter — named in select cases |
Litigation Timeline
May 2014
FDA recommends retrieval within 29-54 days of implantation
2018-2019
Bellwether trials — significant verdicts against Bard
2020-2022
Bard/BD settlement programs resolve thousands of cases
2025-2026
3,800+ total cases filed — most resolved. MDL winding down
Intelligence Signals
No signals yet. Signals populate automatically when scrapers run.
Key Facts
- Status
- active
Geographic Exposure
·D. Ariz. (MDL 2641, Judge Campbell)
·S.D. Ind. (Cook Medical cases)
·Nationwide — most cases resolved through settlement
·Parallel state court proceedings
Eligibility Criteria
- ✓Had an IVC filter implanted (Bard Recovery, G2, Cook Celect, or similar)
- ✓Experienced filter fracture, migration, tilting, or perforation
- ✓Required surgical removal or emergency intervention
- ✓Suffered pulmonary embolism, organ perforation, or death of family member